Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001964306-26-000007
Filing Date
2026-01-05
Accepted
2026-01-05 17:03:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2984
  Complete submission text file 0001964306-26-000007.txt   4469
Mailing Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465
Business Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 617-344-4190
Acumen Pharmaceuticals, Inc. (Subject) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40551 | Film No.: 26507551
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address
Zuga Matt (Reporting) CIK: 0001790214 (see all company filings)

Type: 144